| Recent developments on 1, 2, 4-triazole nucleus in anticancer compounds: a review R Kaur, A Ranjan Dwivedi, B Kumar, V Kumar Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal …, 2016 | 301* | 2016 |
| Promising targets in anti-cancer drug development: recent updates B Kumar, S Singh, I Skvortsova, V Kumar Current medicinal chemistry 24 (42), 4729-4752, 2017 | 150 | 2017 |
| Recent developments on the structure–activity relationship studies of MAO inhibitors and their role in different neurological disorders B Kumar, AK Mantha, V Kumar RSC advances 6 (48), 42660-42683, 2016 | 132 | 2016 |
| Recent advancements in the development of bioactive pyrazoline derivatives B Nehra, S Rulhania, S Jaswal, B Kumar, G Singh, V Monga European journal of medicinal chemistry 205, 112666, 2020 | 125 | 2020 |
| Recent advancements in the development of heterocyclic anti-inflammatory agents S Sharma, D Kumar, G Singh, V Monga, B Kumar European Journal of Medicinal Chemistry 200, 112438, 2020 | 124 | 2020 |
| Insights into the structure activity relationship of nitrogen-containing heterocyclics for the development of antidepressant compounds: An updated review K Singh, R Pal, SA Khan, B Kumar, MJ Akhtar Journal of Molecular Structure 1237, 130369, 2021 | 93 | 2021 |
| Synthesis and biological evaluation of pyrimidine bridged combretastatin derivatives as potential anticancer agents and mechanistic studies B Kumar, P Sharma, VP Gupta, M Khullar, S Singh, N Dogra, V Kumar Bioorganic Chemistry 78, 130-140, 2018 | 85 | 2018 |
| The growing concern of chlorpyrifos exposures on human and environmental health NK Nandi, A Vyas, MJ Akhtar, B Kumar Pesticide biochemistry and physiology 185, 105138, 2022 | 83 | 2022 |
| A perspective on monoamine oxidase enzyme as drug target: challenges and opportunities B Kumar, V Prakash Gupta, V Kumar Current drug targets 18 (1), 87-97, 2017 | 82 | 2017 |
| Mechanisms of tubulin binding ligands to target cancer cells: updates on their therapeutic potential and clinical trials B Kumar, R Kumar, I Skvortsova, V Kumar Current Cancer Drug Targets 17 (4), 357-375, 2017 | 81 | 2017 |
| 4, 6-Diphenylpyrimidine derivatives as dual inhibitors of monoamine oxidase and acetylcholinesterase for the treatment of Alzheimer’s disease B Kumar, AR Dwivedi, B Sarkar, SK Gupta, S Krishnamurthy, AK Mantha, ... ACS Chemical Neuroscience 10 (1), 252-265, 2018 | 79 | 2018 |
| Dipropargyl substituted diphenylpyrimidines as dual inhibitors of monoamine oxidase and acetylcholinesterase B Kumar, V Kumar, V Prashar, S Saini, AR Dwivedi, B Bajaj, D Mehta, ... European journal of medicinal chemistry 177, 221-234, 2019 | 77 | 2019 |
| Medicinal perspective of indole derivatives: recent developments and structure-activity relationship studies D Kumar, S Sharma, S Kalra, G Singh, V Monga, B Kumar Current drug targets 21 (9), 864-891, 2020 | 67 | 2020 |
| Chitosan-supported copper as an efficient and recyclable heterogeneous catalyst for A3/decarboxylative A3-coupling reaction VR Pavneet kaur, Bhupinder kumar Tetrahedron Letters 59 (21), 1986-1991, 2018 | 58 | 2018 |
| Voltage gated sodium channel inhibitors as anticonvulsant drugs: A systematic review on recent developments and structure activity relationship studies R Pal, B Kumar, MJ Akhtar, PA Chawla Bioorganic Chemistry 115, 105230, 2021 | 55 | 2021 |
| Piperazine, a Key Substructure for Antidepressants: Its Role in Developments and Structure‐Activity Relationships RR Kumar, B Sahu, S Pathania, PK Singh, MJ Akhtar, B Kumar ChemMedChem 16 (12), 1878-1901, 2021 | 53 | 2021 |
| Role of vitamins in neurodegenerative diseases: a review RR Kumar, L Singh, A Thakur, S Singh, B Kumar CNS & Neurological Disorders-Drug Targets (Formerly Current Drug Targets-CNS …, 2022 | 50 | 2022 |
| Role of peroxisome proliferator-activated receptor gamma (PPARγ) in different disease states: Recent updates S Mal, AR Dwivedi, V Kumar, N Kumar, B Kumar, V Kumar Current Medicinal Chemistry 28 (16), 3193-3215, 2021 | 47 | 2021 |
| A review on post-traumatic stress disorder (PTSD): symptoms, therapies and recent Case studies A Thakur, D Choudhary, B Kumar, A Chaudhary Current molecular pharmacology 15 (3), 502-516, 2022 | 43 | 2022 |
| Synthesis, biological evaluation and molecular modeling studies of phenyl-/benzhydrylpiperazine derivatives as potential MAO inhibitors B Kumar, AK Mantha, V Kumar Bioorganic Chemistry 77, 252-262, 2018 | 43 | 2018 |
Vinod KumarDepartment of Chemistry, Central University of Punjab, Bathindacup.edu.in의 이메일 확인됨